title: Ethical standards for clinical trials conducted in third countries: the new strategy of the European Medicines Agency.
abstract: Clinical trials increasingly occur on a global scale as industry and government sponsors in wealthy countries move trials to low- and middle-income countries. The globalization of clinical research raises important questions about the economical and ethical aspects of clinical research and the translation of trial results to clinical practice: which ethical standards are applied? Are trials results accurate and valid, and can they be extrapolated to other settings? This article provides an overview of the strategy approved by the European Medicines Agency (EMA) to clarify ethical standards for clinical research conducted outside the European Economic Area (EEA) and included in Marketing Authorization Applications. Reference to the EMA Reflection paper is made.
authors.affiliation: Espace Ethique Méditerranéen (Bioethics Research Centre E.A. 3783), Université de la Méditerranée, Marseille, France.
authors.forename: Annagrazia
authors.initials: A
authors.lastname: Altavilla
mesh_terms: D002986:Clinical Trials as Topic / Q000941:ethics* / Q000592:standards; D003906:Developing Countries; D005060:Europe; D006077:Government Agencies; D006805:Human Experimentation / Q000941:ethics; D006801:Humans